webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Boc-Dap-OH.DCHA

  CAS No.: 1369427-40-6   Cat No.: BADC-01570 4.5  

Boc-Dap-OH.DCHA, a remarkable biomedical compound, emerges as an invaluable arsenal against an array of maladies. Functioning as a potent therapeutic agent, it meticulously identifies and tackles discretely designated pathogens, exhibiting unparalleled efficacy. Within the biomedicine realm, this futuristic product assumes a pivotal position, fostering innovative strategies aimed at conquering the ever-evolving drug-resistant bacterial strains and numerous afflictions of an infectious nature.

Boc-Dap-OH.DCHA

Structure of 1369427-40-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C26H48N2O5
Molecular Weight
468.67

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
dicyclohexylamine (2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate; 2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine 1:1
IUPAC Name
N-cyclohexylcyclohexanamine;(2R,3R)-3-methoxy-2-methyl-3-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]propanoic acid
Canonical SMILES
CC(C(C1CCCN1C(=O)OC(C)(C)C)OC)C(=O)O.C1CCC(CC1)NC2CCCCC2
InChI
InChI=1S/C14H25NO5.C12H23N/c1-9(12(16)17)11(19-5)10-7-6-8-15(10)13(18)20-14(2,3)4;1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h9-11H,6-8H2,1-5H3,(H,16,17);11-13H,1-10H2/t9-,10+,11-;/m1./s1
InChIKey
PKZALTWOMMNNOL-QJQMQQLTSA-N

Boc-Dap-OH·DCHA, also known as N-Boc-D-2,3-diaminopropionic acid dicyclohexylamine salt, stands as a pivotal reagent in synthetic chemistry and pharmaceutical research. Here are four key applications of Boc-Dap-OH·DCHA:

Peptide Synthesis: Serving as a cornerstone in the realm of peptide and protein synthesis, Boc-Dap-OH·DCHA plays a crucial role in constructing intricate peptide sequences. Its distinct side chain offers the flexibility to incorporate functional groups at precise locations along the peptide chain, enabling the creation of peptides with specific biological activities. This versatility is imperative for conducting detailed structure-activity relationship studies and advancing peptide-based therapeutics.

Pharmaceutical Development: Within the domain of drug discovery, Boc-Dap-OH·DCHA contributes significantly to the development of small molecule inhibitors and drugs. Its stereochemical configuration makes it particularly valuable for synthesizing chiral molecules, ultimately enhancing the binding affinity and specificity of drug candidates. By integrating Boc-Dap-OH·DCHA into pharmaceutical compounds, researchers aim to craft more potent and targeted therapeutic agents that hold the promise of improved efficacy in combating various diseases.

Bioconjugation Chemistry: In the realm of bioconjugation techniques, Boc-Dap-OH·DCHA emerges as a critical component for linking bioactive molecules to peptides and proteins. Its amine groups serve as reactive sites for conjugation, facilitating the creation of bioconjugates with enhanced targeting capabilities and efficacy. These bioconjugates play a pivotal role in targeted drug delivery systems and diagnostic imaging strategies.

Protein Engineering: At the forefront of protein engineering endeavors, Boc-Dap-OH·DCHA enables researchers to introduce non-natural amino acids into protein structures, paving the way for the development of novel proteins with enhanced properties. By leveraging this reagent, scientists can engineer proteins with improved stability, unique catalytic activities, and enhanced functionality. These engineered proteins find diverse applications in industrial settings, including biocatalysis processes and the creation of innovative biomaterials, fueling advancements in biotechnology and materials science.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Fmoc-D-Dbu(N3)-OH | SC209 intermediate-2 | Boc-cis-L-4-hydroxyproline methyl ester | EC1167 hydrochloride | Fmoc-D-Trp(Boc)-OH | MAL-tri-EG-OPFP | Methyl azetidine-3-carboxylate hydrochloride | Hydroxy-PEG3-t-butyl ester | Me-Tet-PEG2-COOH | Boc-D-Lys(N3)-OH CHA salt | Boc-Dap-OH.DCHA
Send Inquiry
Verification code
Inquiry Basket